ARCHIVES

Wyden Asks Healy To Clarify CRADA Pricing Clause

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

NCAB Committee Still Debating How To Encourage Surgical Oncology

April 26, 1985

Cancer Center Directors Contemplate the Role of Centers In the 21st Century

May 7, 1999

After Year-Long Review, Varmus Removes “Reasonable Pricing” Clause From CRADA

April 14, 1995

DCT Get Okay to Proceed With Human Cell Line Drug Screening, More Drug Discovery Group

June 19, 1987

Broder Issues Clinical Alert on 5-FU Levamisle Survival Advantage for Dukes C Colon Cancer

October 6, 1989

In Brief: Morgan Named Director Of UAMS Myeloma Institute

April 25, 2014